Featured News

2

Pulmonary arterial hypertension drug studied at UC receives FDA...

April 4, 2024

Clinical research conducted at the University of Cincinnati College of Medicine and UC Health played a role in the U.S. Food and Drug Administration's March 26 approval of WINREVAIRâ„¢ (sotatercept-csrk) for the treatment of pulmonary arterial hypertension (PAH) in adults.

Debug Query for this

Latest News

2

Pulmonary arterial hypertension drug studied at UC receives FDA...

April 4, 2024

Clinical research conducted at the University of Cincinnati College of Medicine and UC Health played a role in the U.S. Food and Drug Administration's March 26 approval of WINREVAIRâ„¢ (sotatercept-csrk) for the treatment of pulmonary arterial hypertension (PAH) in adults.

6

Pitching for Platelets

April 3, 2024

Pitching for Platelets! Exclusive Opportunity for Hoxworth Platelet Donors with the Cincinnati Reds

11

Spectrum News: Ohio Voices comes to Cincinnati

March 26, 2024

Ohio Voices, a video segment produced by Spectrum News, paid a visit to the University of Cincinnati to lift the voices of students, staff and faculty. Nine Bearcats were featured in the recent segment.

14

OncLive and Targeted Oncology: Drug yields long-lasting benefits...

March 22, 2024

OncLive and Targeted Oncology covered research presented by the University of Cincinnati's Thomas Herzog that found patients with perivascular epithelioid sarcoma (PEComa) of gynecologic or peritoneal origin experienced rapid, durable responses when treated with the drug nab-sirolimus.

Load More
Debug Query for this